Indraneel Mittra

Q: What Schools Are Affiliated With Indraneel Mittra

Indraneel Mittra is affiliated with the following schools: Delhi University, Panjab University, University College London, University of Mumbai, Stanford University, Johns Hopkins University

Indraneel Mittra's AcademicInfluence.com Rankings

Indraneel Mittra

Law

#3111

World Rank

#3910

Historical Rank

Common Law

#188

World Rank

#204

Historical Rank

International Law

#1181

World Rank

#1416

Historical Rank

law Degrees

Indraneel Mittra

Engineering

#6840

World Rank

#8189

Historical Rank

Biomedical Engineering

#839

World Rank

#852

Historical Rank

engineering Degrees

Download Badge

Law
Engineering

Indraneel Mittra's Degrees

PhD Biomedical Engineering Johns Hopkins University
Masters Biomedical Engineering Stanford University

Why Is Indraneel Mittra Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Indraneel Mittra, MBBS, PhD. , FRCS , FASc, FNA is an Indian cancer surgeon, basic research scientist, and public health researcher. He is the Dr. Ernest Borges Chair in Translational Research and Professor Emeritus in the Department of Surgical Oncology, Tata Memorial Centre in Mumbai. He established the first dedicated multi-disciplinary Breast Unit in India – a model which has since been adopted by most centers in the country. He pioneered the discipline of clinical research in cancer in India and pursued the cause of improving cancer care in the developing world. In this context, and with an RO1 grant from the National Institutes of Health of the United States, Mittra spearheaded one of the largest randomized trials of screening for early detection of breast and cervical cancer using low-cost technology approaches involving 150,000 women in the suburbs of Mumbai. He is the first Indian recipient of such a competitive grant from the NIH. In the field of laboratory research, he is credited with having discovered the wide-ranging biological activities of cell-free chromatin particles , which have critical implications for human health and disease, and how deactivating cfChPs can have many therapeutic effects.

(See a Problem?)

Indraneel Mittra's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Locoregional treatment versus no treatment of the primary tumour in metastatic breast cancer: an open-label randomised controlled trial. (2015) (373)
A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening (2009) (194)
Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India. (2014) (190)
A novel "cleaved prolactin" in the rat pituitary: part I. Biosynthesis, characterization and regulatory control. (1980) (126)
Hypothalamic-pituitary-thyroid axis in breast cancer. (1974) (99)
A novel "cleaved prolactin" in the rat pituitary: Part II. In vivo mammary mitogenic activity of its N-terminal 16K moiety. (1980) (82)
Breast screening in the emerging world: high prevalence of breast cancer in Cairo. (2005) (81)
Circulating nucleic acids damage DNA of healthy cells by integrating into their genomes (2015) (77)
Hypothalamic-pituitary-prolactin axis in breast cancer. (1974) (74)
Role of ultrasonography to detect axillary node involvement in operable breast cancer. (1996) (71)
Single-injection depot progesterone before surgery and survival in women with operable breast cancer: a randomized controlled trial. (2011) (70)
Nucleic acids in circulation: Are they harmful to the host? (2012) (68)
The TNM staging system and breast cancer. (2003) (67)
Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai (2020) (61)
Thyroid and other autoantibodies in British and Japanese women: an epidemiological study of breast cancer. (1976) (60)
A meta-analysis of reported correlations between prognostic factors in breast cancer: does axillary lymph node metastasis represent biology or chronology? (1991) (58)
Breast screening: the case for physical examination without mammography (1994) (55)
Mammotropic effect of prolactin enhanced by thyroidectomy (1974) (52)
Abstract S2-02: Surgical removal of primary tumor and axillary lymph nodes in women with metastatic breast cancer at first presentation: A randomized controlled trial (2013) (48)
POSSIBLE RESONANCES IN THE $pi$ AND KK SYSTEM (1962) (47)
Multicentricity and recurrence of breast cancer (1997) (47)
Scaling properties of charged particle multiplicity distributions in oxygen induced emulsion interactions at 14.6, 60 and 200 A GeV (1989) (45)
Cell-free chromatin from dying cancer cells integrate into genomes of bystander healthy cells to induce DNA damage and inflammation (2017) (40)
Rapidity densities and their fluctuations in central 200 A GeV 32S interactions with Au and Ag, Br nuclei EMU01 collaboration (1989) (36)
Effect of visual inspection with acetic acid (VIA) screening by primary health workers on cervical cancer mortality: A cluster randomized controlled trial in Mumbai, India. (2013) (35)
Multiplicity in proton-nucleus interactions at 200 GeV/c (1974) (33)
Prognosis of operable squamous cell carcinoma of the esophagus. Relationship with clinicopathologic features and DNA ploidy (1993) (31)
In utero exposure to methyl isocyanate in the Bhopal gas disaster: evidence of persisting hyperactivation of immune system two decades later (2008) (30)
Prevention of radiation-induced bystander effects by agents that inactivate cell-free chromatin released from irradiated dying cells (2018) (29)
Slow, target associated particles produced in ultrarelativistic heavy-ion interactions (1991) (29)
Prognosis of breast cancer: Evidence for interaction between c‐erbB‐2 overexpression and number of involved axillary lymph nodes (1995) (29)
Produced particle multiplicity dependence on centrality in nucleus-nucleus collisions (1996) (29)
Energy dependence of multiplicity in proton-nucleus collisions and models of multiparticle production (1974) (28)
Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer. (2013) (28)
Prevention of chemotherapy toxicity by agents that neutralize or degrade cell-free chromatin (2017) (28)
On intermittency in heavy-ion collisions and the importance of γ-conversion in a multi-dimensional intermittency analysis (1992) (28)
On the systematic behaviour of the intermittency-indices in nuclear interactions (1991) (28)
Fragmentation and multifragmentation of 10.6A GeV gold nuclei (1999) (28)
Charged particle density distributions in Au induced interactions with emulsion nuclei at 10.7 A GeV (1995) (27)
Clinico-pathological features and prognosis of breast cancer in different religious communities in India. (1990) (27)
Charged Particle Multiplicity in 400-GeV/c p Nucleus Interactions in Nuclear Emulsion (1977) (27)
Bounce – off in 197Au induced collisions with Ag(Br) nuclei at 11.6 A GeV/c (1998) (26)
Validation of EORTC quality-of-life questionnaire in Indian women with operable breast cancer. (2005) (26)
Topological cross sections and charged particle multiplicities inpp interactions at 360 GeV/c (1984) (25)
Breast cancer screening in developing countries. (2011) (25)
Why Is Modern Medicine Stuck in a Rut? (2009) (24)
Inclusiveπ° production in 360 GeVpp interactions using the european hybrid spectrometer (1984) (23)
Somatomedins and proteolytic bioactivation of prolactin and growth hormone (1984) (23)
K+n charge exchange reaction at 3 GeV/c (1968) (22)
Pullulan-histone antibody nanoconjugates for the removal of chromatin fragments from systemic circulation. (2013) (21)
Oestrogen increases S-phase fraction and oestrogen and progesterone receptors in human cervical cancer in vivo. (1997) (21)
Breast cancer in a tertiary cancer center in India - An audit, with outcome analysis. (2018) (21)
Azimuthal anisotropy in S+Au reactions at 200 A GeV (1997) (21)
Evidence for cell-free nucleic acids as continuously arising endogenous DNA mutagens. (2016) (19)
Axillary lymph node metastasis in breast cancer: prognostic indicator or lead-time bias? (1993) (19)
Local particle densities and global multiplicities in central heavy ion interactions at 3.7, 14.6, 60 and 200A GeV (1992) (18)
InclusiveKs/0, Λ and $$\bar \Lambda $$ production in 360 GeV/cp p interactions using the European hybrid spectrometer (1985) (18)
Strangeness and diquark suppression factors in 360 GeV/c pp interactions (1987) (18)
Study of Charged Particle Multiplicity in 50 GeV/c π^- -Emulsion Interaction (1978) (18)
Multiparticle production in proton-nucleus collisions at 360 GeV/c using the European Hybrid Spectrometer (1987) (17)
A search for non-statistical particle density fluctuations in 16O + Ag(Br) and 32S + Au interactions at 200 A GeV (1989) (17)
Estrogen & progesterone receptors measurement in breast cancer with enzyme-immunoassay & correlation with other prognostic factors. (1992) (17)
Early detection of breast cancer in industrially developing countries. (1995) (17)
Resveratrol and Copper for treatment of severe COVID-19: an observational study (RESCU 002) (2020) (17)
Bose-Einstein correlations for pions produced inp p collisions at 360 GeV/c (1989) (16)
EARLY DETECTION OF BREAST CANCER IN DEVELOPING COUNTRIES (1989) (16)
Charm production in 400 GeV/c proton-emulsion interactions (1982) (16)
Multifragmentation of gold nuclei in the interactions with photoemulsion nuclei at 10.7-GeV/nucleon (1997) (15)
Rapidity dependence of multiplicity distributions in proton-nucleus collisions at 360 GeV/c (1988) (15)
On the multiplicity fluctuations in relativistic heavy ion collisions (1990) (15)
Production of K ∗ (892) in K + N interactions at 3 GeV/ c (1970) (15)
K 2 0 Decays and Interactions (1961) (15)
The disconnection between tumor response and survival (2007) (15)
Screening for breast cancer: is it globally applicable? (2008) (15)
28Si(32S) fragmentation at 3.7 A, 14.6 A and 200 A GeV (1995) (15)
Complex analysis of gold interactions with photoemulsion nuclei at 10.7 GeV/nucleon within the framework of cascade and FRITIOF models (1997) (14)
A paradoxical synergism between Resveratrol and copper (II) with respect to degradation of DNA and RNA. (2015) (14)
Illegitimate and Repeated Genomic Integration of Cell-Free Chromatin in the Aetiology of Somatic Mosaicism, Ageing, Chronic Diseases and Cancer (2019) (13)
Timing of surgery during the menstrual cycle and prognosis of breast cancer (2000) (13)
Target nucleus fragmentation in 16O+(Ag,Br) interactions at 200 A GeV (1990) (13)
Test of a quark-diquark fragmentation mechanism in proton-proton interactions at 360 GeV/c (1986) (13)
ON THE ENERGY AND MASS DEPENDENCE OF THE MULTIPLICITY IN RELATIVISTIC HEAVY-ION INTERACTIONS (1990) (13)
Circulating nucleic acids: a new class of physiological mobile genetic elements (2015) (12)
Multiplicity and pseudorapidity distribution of photons in S+Au reaction at 200A GeV (1998) (12)
Guidelines for locoregional therapy in primary breast cancer in developing countries: The results of an expert panel at the 8th Annual Women's Cancer Initiative – Tata Memorial Hospital (WCI-TMH) Conference (2012) (11)
Angular distributions of light projectile fragments in deep inelastic Pb + Em interactions at 160 A GeV (1999) (11)
A comparative study of detection of p53 mutations in human breast cancer by flow cytometry, single-strand conformation polymorphism and genomic sequencing. (1996) (11)
Cell-free chromatin particles released from dying host cells are global instigators of endotoxin sepsis in mice (2020) (11)
Helium production in 10.7 A GeV Au induced nucleus-nucleus collisions (1994) (10)
Nuclear effect in higher dimensional factorial moment analysis of the O-16, S-32 and Au-197 emulsion interaction data at 200-A/Gev, 60-A/GeV/c and 11-A/GeV/c (1997) (10)
A study of recoil protons in ultra-relativistic nucleus-nucleus collisions (1989) (10)
STRANGE PARTICLE PRODUCTION BY 4.65-Bev/c $pi$$sup -$ MESONS (1963) (10)
Prognostic association of c-erbB-2 oncogene amplification and protein overexpression in human breast cancer using archival tissues. A comparative study. (1994) (9)
A paradoxical relationship between Resveratrol and copper (II) with respect to degradation of DNA and RNA (2016) (9)
Two-source emission of relativistic alpha particles in 40Ar-emulsion collisions (1989) (9)
Analysis of BRCA1 involvement in breast cancer in Indian women (2000) (9)
Is inflammation a direct response to dsDNA breaks? (2018) (9)
Coherent K∗ production in K+d reactions at 3 GeV/c (1969) (9)
Physical shearing imparts biological activity to DNA and ability to transmit itself horizontally across species and kingdom boundaries (2017) (9)
The reactions K+d → K+d, K+d → K+pn and K+d → K0pp at 3 Ge V/c with an investigation of K+n scattering (1972) (8)
Charged particle multiplicities, densities and fluctuations in Pb+Pb interactions at 158 A GeV (1997) (8)
Functional Maps of Metastases from Breast Cancers: Proof of the Principle that Multidimensional Scaling Can Summarize Disease Progression (2004) (8)
Timing of surgery with regard to the menstrual cycle in women with primary breast cancer. (1999) (8)
Cytokine Storm as a Cellular Response to dsDNA Breaks: A New Proposal (2021) (7)
Cell-free chromatin: A newly described mediator of systemic inflammation (2019) (7)
He production in 158 A GeV/c Pb on Pb interactions (1997) (7)
Multifractal analysis of particles produced in 197Au, 32S and 16O induced interactions at high energies (1998) (7)
Multiparticle production in π−-emulsion collisions at 340 GeV/c (1985) (7)
Fraction of normal remaining life span: a new method for expressing survival in cancer (1997) (7)
Soft Photon Production in Central 200 GeV/Nucleon ^{32}S+Au Collisions (1997) (7)
Differences in oestrogen receptor status and histological grade of breast cancer in different religious communities in Bombay. (1991) (6)
On the Interactions of 17.2 Gev π- with Light and Heavy Emulsion Nuclei (1967) (6)
Study of rapidity-gap correlations in 400-GeV/c p-N interactions (1979) (6)
DNA analysis of breast cancer by flow cytometry & correlation with other prognostic parameters. (1992) (6)
Rapidity-Gap Correlation in Proton-Nucleus Interactions at 200 and 400 GeV/c (1982) (6)
Sentinel node biopsy in operable breast cancer (2003) (6)
Inclusive pion production in 360 GeV/cpp interactions (1987) (6)
Rapidity density distributions and their fluctuations in violent Au-induced nuclear interactions at 11.6 A GeV/ c (1994) (6)
Two-particle correlations in 360 GeV/cp p interactions (1988) (6)
Event by event measurement of 〈pT〉 of photons in S + Au collisions at 200 A·GeV (1997) (6)
Intraop catheter in internal mammary vessel (IMV): a novel technique for internal mammary nodal (IMC) irradiation with HDR brachytherapy (2003) (5)
Origin of Genome Instability and Determinants of Mutational Landscape in Cancer Cells (2020) (5)
PRODUCTION OF CLUSTERS IN PI- N AND PI- C INTERACTIONS AT 40-GEV/C (1982) (5)
A New Perspective on the Origin of DNA Double-Strand Breaks and Its Implications for Ageing (2021) (5)
Correlations between c-erb beta-2 oncogene amplification and the expression of its mRNA and protein in human breast carcinomas. (1992) (5)
Has adjuvant treatment of breast cancer had an unfair trial? (1990) (5)
Limiting Fragmentation, Scaling and Substructual Dependence of Multiparticle Production in High Energy Heavy Ion Reactions (1990) (5)
Review of recent results on particle production from EMU01 (1992) (5)
Surgical removal of primary tumor in metastatic breast cancer: Impact on health-related quality of life (HR-QOL) in a randomized controlled trial (RCT). (2014) (5)
PROPERTIES OF THE $sup -$ HYPERON (1962) (5)
Studies of $$\bar pp \to \bar nn$$ and $$\bar np$$ annihilation at incident momenta of 700 and 760 MeV/c (1985) (4)
Overview of breast cancer in India (2006) (4)
InclusiveK*'s and∑*'s production in 360 GeV/cpp interactions using the European hybrid spectrometer (1986) (4)
Particle correlations in multiparticle production in proton-nucleus interactions at 200 and 400 GeV (1984) (4)
Ethics of "standard care" in randomised trials of screening for cervical cancer should not ignore scientific evidence and ground realities. (2013) (4)
Cancer research: in need of introspection. (2016) (3)
Characteristics of p-N Interactions at 400 GeV/c in Emulsion (1980) (3)
Potency of thyroid hormone analogues in suppressing prolactin-mediated mammary growth in thyroidectomized rats (1975) (3)
STUDY OF INELASTIC α-EMULSION INTERACTIONS AT 12A GeV/c (1988) (3)
Progesterone Before Surgery and Survival in Women With Operable Breast Cancer: A Randomized Controlled Trial. (2011) (3)
New method of expressing survival in cancer is popular (1998) (3)
Clinical Significance of Serum Spermine in Breast Cancer (1988) (3)
Nucleus-nucleus collision as superposition of nucleon-nucleus collisions (1999) (3)
Characteristics of fireballs in 400 GeV/c proton-nucleon collisions (1978) (3)
A pro-oxidant combination of resveratrol and copper down-regulates multiple biological hallmarks of ageing and neurodegeneration in mice (2022) (3)
A novel pro-oxidant combination of resveratrol and copper reduces transplant related toxicities in patients receiving high dose melphalan for multiple myeloma (RESCU 001) (2022) (3)
Cascade model analysis of the interactions of 17.2 GeV mesons with heavy emulsion nuclei (1967) (3)
Particle production in gold and lead induced interactions at AGS and SPS (1995) (3)
Mechanism of hadron production in proton-nucleus interactions at 400 GeV (1982) (3)
On the production of slow particles in high energy heavy ion collisions (1995) (3)
Screening for breast cancer in India. (1993) (3)
A systematic study of the energy independent behaviour of the fragmentation regions in16O-Em interactions from 3.7 to 200A GeV (1992) (2)
Experimental study of proton-emulsion nuclei interactions at high energy (1984) (2)
Improving cancer care world wide. (1993) (2)
STUDY OF ANGULAR DISTRIBUTION OF HELIUM PROJECTILE FRAGMENTS IN INTERACTIONS OF 200 A GeV 32S IONS WITH EMULSION NUCLEI (1993) (2)
Experimental results on proton diffractive dissociation (1990) (2)
Clinical cancer trials in developing countries (1997) (2)
Mammotrophic effect of prolacting enhanced by throidectomy (1974) (2)
RAPIDITY DISPERSION AND CLUSTER SIZE DETERMINATION IN α-EMULSION INTERACTIONS AT 12A GeV/c (1988) (2)
The Lancet Breast Cancer Commission: tackling a global health, gender, and equity challenge (2022) (2)
Characteristics of Slow Protons and Deuterons in Proton-Nucleus Interactions at 400 GeV/c (1980) (2)
Abstract LB-103: Circulating chromatin is a novel DNA damaging agent that induces genomic instability and malignant transformation (2010) (2)
General features ofK+d interactions at 70 GeV/c (1988) (2)
Study of angular distributions of secondaries in proton-nucleus interactions at 400 GeV (1979) (2)
A study of $$\bar np$$ annihilations between 0.5 and 0.8 GeV/c (1986) (2)
Multiple production in pion-nucleus interactions in the additive quark model (1988) (2)
Oestrogen and progesterone receptor estimation by enzyme-immunoassay on tissues removed before and after a modified radical mastectomy. (1993) (2)
Momentum characteristics of slow protons, deuterons, and pions in high energy interactions (1983) (1)
Impact of pre-operative serum C-reactive protein and cell-free chromatin levels on tumor aggressiveness and survival outcome in oral cavity squamous cell carcinoma. (2020) (1)
A pro-oxidant combination of resveratrol and copper reduces chemotherapy-related non-haematological toxicities in advanced gastric cancer: results of a prospective open label phase II single-arm study (RESCU III study) (2022) (1)
Charged charm production in proton-emulsion interactions at 400 GeV/c (1985) (1)
A study of angular correlations of projectile and target fragments in 1.4 A GeV Kr+Ag(Br) collisions (1989) (1)
Cell-free chromatin particles released from dying cells inflict mitochondrial damage and ROS production in living cells (2021) (1)
Results from the WA93 photon multiplicity detector (1995) (1)
Study of Λ-production in target fragmentation region frompp interactions at 360 GeV/c in the triple regge framework (1985) (1)
STUDY OF CLUSTERS AND HEAVY CLUSTERS IN α-EMULSION INTERACTIONS AT 12A GEV/C (1989) (1)
The sentinel node debate in breast cancer. (2008) (1)
Rapidity dependence of multiplicity distributions in alpha-emulsion interactions at 12. 4A GeV (1990) (1)
Keeping abreast of the issues (2005) (1)
A pro-oxidant combination of resveratrol and copper down-regulates hallmarks of cancer and immune checkpoints in patients with advanced oral cancer: Results of an exploratory study (RESCU 004) (2022) (1)
The Role of Grey Tracks in Proton-Emulsion Nuclei Interactions at 400 GeV (1982) (1)
Multicentricity of breast cancer: new findings and their clinical and biological implications (1997) (1)
Local recurrence of breast cancer: new concepts about its biology and clinical relevance (1997) (1)
Photon multiplicity measurements in nucleus-nucleus collisions at 200 A GeV (1994) (1)
Prognostic significance of DNA index by flowcytometry in acute lymphoblastic leukaemia. (1995) (1)
Neutral charm production in 400 GeV proton-emulsion interactions (1984) (1)
In screening for breast cancer, clinical examination is as effective as mammography (1997) (1)
Unexpected failures … and successes (1997) (1)
An Inverse Relationship Between Intracellular Prolactin and Growth Hormone and Estrogen Receptor Status in Human Breast Cancers (1987) (0)
Circulating nucleic acids damage DNA of healthy cells by integrating into their genomes (2015) (0)
The dynamics of circulating nucleosomes following chemotherapy for breast cancer. (2014) (0)
Study of inclusive production of Λ-hyperons in the target fragmentation region in pp interactions at 360 GeV/c by a triple Regge analysis (1986) (0)
Abstract 2875: Metastases arise as new cancers from cells of target organs transformed by cell-free chromatin particles released from dying circulating tumor cells (2021) (0)
ON THE INTERACTION OF 17.2 GeV $pi$$sup -$ WITH LIGHT AND HEAVY EMULSION NUCLEI. (1967) (0)
Search for Anomalons in Projectile Fragments for AR.- Emulsion Interactions at 1.8 a GEV (1983) (0)
0-86. Local recurrence of breast cancer: new concepts about its biology and clinical relevance (1997) (0)
Natural history of ductal carcinoma in situ should be viewed from a public health perspective (1999) (0)
Fragmentation of relativistic gold nuclei in nuclear emulsion (1995) (0)
Therapeutic interventions on human xenografts promote systemic dissemination of oncogenes (2023) (0)
Current perspectives in breast cancer : proceedings of the International Symposium on Breast Cancer held in New Delhi, India, January 1-4, 1987 (1988) (0)
Abstract 2514: Cell-free chromatin particles released into the microenvironment from dying tumor cells activate cancer hallmarks in surviving cells: a study in advanced squamous cell carcinoma of oral cavity with therapeutic implications (2021) (0)
Mishandling misconduct: the breast cancer trials scandal. (1994) (0)
S-and Au-em Interaction Data at 200, 60 and 11 a Gev/c Emu-01 Collaboration (1997) (0)
Multicentricity and recurrence of breast cancer (multiple letters) [15] (1997) (0)
A comparative study of dextran coated charcoal (DCC) and enzyme immunoassay (EIA) methods for oestrogen receptor (ER) estimation in breast cancer. (1991) (0)
Oncology. Unexpected failures ... and successes. (1997) (0)
Atlas of Breast Cancer, Second Edition (2001) (0)
Screening for breast cancer: Cost-effective solutions for low- & middle-income countries (2021) (0)
Fragmentation and multifragmentation of 10 . 6 A GeV gold nuclei The EMU-01 Collaboration (1998) (0)
Decay of a Negative Hyperon into ?^{0}+e^{-}+?[over ] (1962) (0)
172P Long-term follow-up of randomized controlled trial (RCT) of locoregional treatment versus not of the primary tumour in de-novo metastatic breast cancer (2022) (0)
DECAY OF A NEGATIVE HYPERON INTO $lambda$$sup 0$ + e$sup -$ + anti$nu$ (1962) (0)
Sentinel node biopsy in breast cancer (2001) (0)
Violent Au induced collisions at the BNL AGS and comparisons with expectations from particle densities and their fluctuations in collisions with lighter systems (1993) (0)
MEDICINE IN TWO SOCIETIES –INDIA AND BRITAIN (1973) (0)
Fraction of normal remaining life: a new method to express survival in chronic diseases (1997) (0)
Tracking high energy heavy-ion interactions with nuclear emulsion (1995) (0)
Does outcome of breast cancer depend on dose and dose intensity of adjuvant chemotherapy? (1994) (0)
Abstract 2067: Genomic integration of circulating cell-free chromatin particles activates all known hallmarks of cancer and Immune checkpoint PDL-1 (2021) (0)
MASS MEASUREMENTS IN NUCLEAR EMULSIONS BY MULTIPLE SCATTERING AND GAP DISTRIBUTION (1956) (0)
Consensus guidelines and clinical practice in breast cancer. (1991) (0)
Nucleic acids in circulation: Are they harmful to the host? (2012) (0)
Tamoxifen in the news ... again! (1998) (0)
Cell-free chromatin: A newly described mediator of systemic inflammation (2019) (0)
The p53 tumour suppressor gene and human cancer. (1994) (0)
Multiparticle production in proton-nucleus collisions at 360 GeV/c using the European Hybrid spectrometer (1987) (0)
Multiplicity in proton-nucleus collisions at 200 GeV/c and models of multiparticle production (1974) (0)
ES5-1: Breast Cancer Trials in Developing Countries - Opportunities and Challenges. (2011) (0)
Investigation of R-bar v relationship in hadron-nucleus collisions at high energies (1989) (0)
Study of Elastic (π-p) and Coherent (π-C) Cross-Section at 40 GeV/c Using Propane (C3H8) Bubble Chamber (1979) (0)
The new method of expressing survival in cancer is popular (Author's reply) (1998) (0)
Particle production, density fluctuations and breakup of dense nuclear matter in central Pb + Ag and Pb + Pb interactions at 60-A/GeV - 160-A/GeV. (1991) (0)
Fraction of normal remaining life: a new method of defining cure in early breast cancer (1997) (0)
How does Egypt cope (2004) (0)
Clinical experience of UK medical (1998) (0)
Biology of cell-free nucleic acids and its role in initiation and metastasis of cancer (2017) (0)
The familial breast cancer genes--the end or the beginning? (1995) (0)
Adjuvant systemic therapy for breast cancer. (1995) (0)
MULTICENTRICITY AND RECURRENCE OF BREAST CANCER. AUTHORS' REPLIES (1997) (0)
Sentinel-node biopsy in breast cancer (2001) (0)
Intranuclear cascade in the interactions of neutrinos with neon nuclei (2000) (0)
Linear and nonlinear aspects of relativistic heavy ion interactions from EMU01 results (2008) (0)
ON THE PROJECTILE MASS DEPENDENCE OF AZIMUTHAL CORRELATIONS IN INTERACTIONS WITH EMULSION TARGET NUCLEI (1989) (0)
Prevention of radiation-induced bystander effects by agents that inactivate cell-free chromatin released from irradiated dying cells (2018) (0)
EUROPEAN ORGANIZATION FOR NUCLEAR RESEARCH CERN–PPE/97–01 8 January 1997 A MEASUREMENT OF THE HOLOGRAPHIC MINIMUM-OBSERVABLE BEAM BRANCHING RATIO IN THE FERMILAB 15-FOOT BUBBLE CHAMBER E-632 Collaboration (1997) (0)
0-68. Fraction of normal remaining life: a new method of defining cure in early breast cancer (1997) (0)
On the production mechanism of deuterons in proton-nucleus interactions at 400 GeV/c (1980) (0)
THE CAIRO BREAST SCREENING STUDY (CBCST) (2009) (0)

This paper list is powered by the following services:

Other Resources About Indraneel Mittra

en.wikipedia.org

What Schools Are Affiliated With Indraneel Mittra?

Indraneel Mittra is affiliated with the following schools:

Indraneel Mittra's Academic­Influence.com Rankings

Indraneel Mittra's Degrees

Why Is Indraneel Mittra Influential?

Indraneel Mittra's Published Works

Published Works

Other Resources About Indraneel Mittra

What Schools Are Affiliated With Indraneel Mittra?

Indraneel Mittra's AcademicInfluence.com Rankings